Corporate Profile

About ResMed

ResMed (NYSE: RMD and ASX: RMD.AX) is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and other respiratory disorders. ResMed operates in over 68 countries via 18 direct o... More >>

Receive E-mail AlertsE-mail Alert Icon
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Recent Event
Credit Suisse Healthcare Conference
Wednesday, November 11, 2009 2:30 p.m. PT
Stock Quote
ExchangeNYSE (US Dollar)
Price$50.25
Change (%) Stock is Down 0.42 (0.83%)
Volume609,465
Data as of 11/20/09 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
Presentations
DateTitle
11/10/09
Q1 2010 Investor Presentation
Recent NewsMore >>
DateTitle 
11/05/09ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009
SAN DIEGO, Nov. 5 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income results for the quarter ended September 30, 2009. Revenue for the September 2009 quarter was $247.0 million, a 13% increase (a 16% increase on a constant currency basis) over the quarter ended September 30, 2008. For the quarter ended September 30, 2009, income from operations was $52.7 million and net income was $42.1 million, an increase of 44% and 50%, respectively, compared to the ... 
Printer Friendly Version
10/15/09ResMed Announces Conference Call and Webcast to Discuss First Quarter 2010 Results
SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD), announced today that on Thursday, November 5, 2009, it will release its results for the first quarter of fiscal year 2010, ended September 30, 2009. A press release with ResMed's results will be issued after 1:00 p.m. Pacific Time and the Company will host a conference call and webcast to review its results, market trends, and future outlook. The conference call is scheduled to begin at 1:30 p.m. Pacific Time and ... 
Printer Friendly Version
10/05/09ResMed Acquires Laboratoires Narval
Expands Current Therapy Range and Patient Reach through Acquisition SAN DIEGO, Oct. 5 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced today that it has acquired Laboratoires Narval. Based in France, Laboratoires Narval manufactures and distributes the Narval O.R.M.(TM), an innovative mandibular repositioning device (MRD) that offers a solution to patients for snoring and obstructive slee... 
Printer Friendly Version
08/10/09ResMed Inc. to Present at Upcoming Investor Conferences
SAN DIEGO, Aug 10, 2009 /PRNewswire-FirstCall via COMTEX/ -- ResMed Inc. (NYSE: RMD) announced today that they will be presenting at three upcoming investor conferences. Kieran Gallahue, President and CEO will be presenting at the Canaccord Adams Global Growth Conference at the Intercontinental Boston Hotel in Boston on August 12, 2009 at 9:00 a.m. US Eastern Time David Pendarvis, SVP, Organization Development and General Counsel will be presentin... 
Printer Friendly Version
Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.


Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet

©2000-2008 ResMed. All rights reserved.